We investigated the role of
cyclin A in the cytotoxic effect of
5-fluorouracil (5-FU) on
cancer cell lines. Experiments were performed using
gastric cancer chemosensitive NUGC3, and chemoresistant NUGC3/
5FU/L established by repeated exposure to
5-FU.
5-FU inhibited cell growth of NUGC3 in a dose-dependent manner. Low concentrations of
5-FU did not inhibit cell growth of NUGC3/
5FU/L, while high concentrations slightly inhibited cell growth. Examination of the cell cycle pattern of NUGC3 cells showed accumulation at S-phase
at 10 micro M and at G1-S-phase at 100 micro M of
5-FU. Cell cycle pattern of NUGC3/
5FU/L cells did not change
5-FU concentrations.
5-FU increased
cyclin A mRNA level in NUGC3 cells but not NUGC3/
5FU/L cells. In the presence of 100 micro M
5-FU,
cyclin A protein level increased 2.6-fold in NUGC3 and 1.47-fold in NUGC3/
5FU/L.
5-FU dose-dependently increased the percentage of
cyclin A-positive NUGC3 cells, but not NUGC3/
5FU/L cells. The percentage of
cyclin A-positive cells in other
5-FU sensitive esophageal, colon and
gastric cancer cell lines (T.Tn, LOVO, DLD-1, MKN-7), increased in the presence of 1 and 10 micro M
5-FU, while
cyclin A-positive cells in
5-FU resitant hepatocellular and colon
carcinoma cell lines (HCC50 and C-1), did not increase with the same treatment. Our results indicate that the cytotoxic effects of
5-FU in human
cancer cell lines correlate with
cyclin A and it may be used as a predictive factor for
chemotherapy response.